✦ LIBER ✦

Continuous infusion 5-fluorouracil with escalating doses of intermittent cisplatin and etoposide. A phase I study

✍ Scribed by Thomas Saphner; Douglass C. Tormey; Mark Albertini

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 401 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19911201)68:11<2359::aid-cncr2820681105>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of cisplatin in hyperton

A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies

✍ Leonard Saltz; David Kelsen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 1 views

5-fluorouracil and methotrexate administ

5-fluorouracil and methotrexate administered simultaneously as a continuous infusion. A phase I study

✍ Jacob J. Lokich; Donald Phillips; Robert Green; Steven Paul; Henry Sonneborn; Th 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

Phase I study of protracted venous infus

Phase I study of protracted venous infusion of 5-fluorouracil

✍ J. Lokich; A. Bothe; N. Fine; J. Perri 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

A phase I and pharmacology study of cont

A phase I and pharmacology study of continuous-infusion low-dose methotrexate administration

✍ Jacob J. Lokich; Gregory Curt 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

A phase I study of chronic daily dosing

A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer

✍ Masahiro Fukuoka; Noriyuki Masuda; Shunichi Negoro; Minoru Takada; Shinzoh Kudoh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 2 views

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer